Research advances in the role of neutrophil extracellular traps in childhood-onset systemic lupus erythematosus

LI Lu; FU Hai-Dong

doi:10.7499/j.issn.1008-8830.2018.03.016

PDF(905 KB)

Chinese Journal of Contemporary Pediatrics ›› 2018, Vol. 20 ›› Issue (3) : 251-255. DOI: 10.7499/j.issn.1008-8830.2018.03.016

REVIEW

Research advances in the role of neutrophil extracellular traps in childhood-onset systemic lupus erythematosus

LI Lu, FU Hai-Dong

Author information +

History +

Abstract

Neutrophil extracellular traps (NETs) represent a form of cell death distinct from apoptosis or necrosis. The imbalance between the formation and degradation of NETs has long been considered to be closely associated with the activity of autoimmune diseases such as systemic lupus erythematous (SLE). Reactive oxygen species derived from the nicotinamide adenine dinucleotide phosphate oxidase pathway or mitochondrial DNA pathway play a key role in the primary stage of NETs formation. The exposure or delayed degradation of abundant autoantigens, such as double-strand DNA, caused by abnormal activation of neutrophils can induce autoantibody to form immune complexes that deposit in local tissues and then induce the plasmacytoid dendritic cells to secrete the interferon alpha and other inflammatory factors. Those inflammatory factors will eventually cause endothelial cell injury. In order to provide a theoretical basis for targeted therapy and diagnosis of childhood-onset SLE, this paper reviews the role of NETs in the pathogenesis of SLE.

Key words

Neutrophil extracellular trap / Mitochondrial DNA pathway / Systemic lupus erythematous / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LI Lu, FU Hai-Dong. Research advances in the role of neutrophil extracellular traps in childhood-onset systemic lupus erythematosus[J]. Chinese Journal of Contemporary Pediatrics. 2018, 20(3): 251-255 https://doi.org/10.7499/j.issn.1008-8830.2018.03.016

References

[1] Papadimitraki ED, Isenberg DA. Childhood-and adult-onset lupus:an update of similarities and differences[J]. Expert Rev Clin Immunol, 2009, 5(4):391-403.
[2] Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004, 303(5663):1532-1535.
[3] Nathan C. Neutrophils and immunity:challenges and opportunities[J]. Nat Rev Immunol, 2006, 6(3):173-182.
[4] Sangaletti S, Tripodo C, Chiodoni C, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity[J]. Blood, 2012, 120(15):3007-3018.
[5] Borregaard N. Neutrophils, from marrow to microbes[J]. Immunity, 2010, 33(5):657-670.
[6] Yipp BG, Kubes P. NETosis:how vital is it[J]. Blood, 2013, 122(16):2784-2794.
[7] Mantovani A, Cassatella MA, Costantini C, et al. Neutrophils in the activation and regulation of innate and adaptive immunity[J]. Nat Rev Immunol, 2011, 11(8):519-531.
[8] Pilsczek FH, Salina D, Poon KK, et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to staphylococcus aureus[J]. J Immunol, 2010, 185(12):7413-7425.
[9] Hu N, Westra J, Kallenberg CG. Dysregulated neutrophil-endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides:implications for pathogenesis and disease intervention[J]. Autoimmun Rev, 2011, 10(9):536-543.
[10] Warnatsch A, Ioannou M, Wang Q, et al. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis[J]. Science, 2015, 349(6245):316-320.
[11] Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure[J]. Science, 2013, 339(6116):161-166.
[12] Mitroulis I, Kambas K, Chrysanthopoulou A, et al. Neutrophil extracellular trap formation is associated with IL-1 and autophagyrelated signaling in gout[J]. PLoS One, 2011, 6(12):e29318.
[13] Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus[J]. Sci Transl Med, 2011, 3(73):73-92.
[14] Li P, Li M, Lindberg MR, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps[J]. J Exp Med, 2010, 207(9):1853-1862.
[15] Rother N, Pieterse E, Lubbers J, et al. Acetylated histones in apoptotic microparticles drive the formation of neutrophil extracellular traps in active lupus nephritis[J]. Front Immunol, 2017, 8:1136.
[16] Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE[J]. Nat Rev Rheumatol, 2011, 7(12):691-699.
[17] Gupta AK, Joshi MB, Philippova M, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death[J]. FEBS Lett, 2010, 584(14):3193-3197.
[18] Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps[J]. J Cell Biol, 2007, 176(2):231-241.
[19] Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease[J]. Nat Med, 2016, 22(2):146-153.
[20] Hakkim A, Fürnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis[J]. Proc Natl Acad Sci USA, 2010, 107(21):9813-9818.
[21] Leffler J, Martin M, Gullstrand B, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease[J]. J Immunol, 2012, 188(7):3522-3531.
[22] Zykova SN, Tveita AA, Rekvig OP. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis[J]. PLoS One, 2010, 5(8):e12096.
[23] Wermeling F, Chen Y, Pikkarainen T, et al. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus[J]. J Exp Med, 2007, 204(10):2259-2265.
[24] Campbell AM, Kashgarian M, Shlomchik MJ. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus[J]. Sci Transl Med, 2012, 4(157):157ra141.
[25] Söderberg D, Segelmark M. Neutrophil extracellular traps in vasculitis, friend or foe?[J]. Curr Opin Rheumatol, 2018, 30(1):16-23.
[26] Midgley A, McLaren Z, Moots RJ, et al. The role of neutrophil apoptosis in juvenile systemic lupus erythematosus[J]. Arthritis Rheum, 2009, 60(8):2390-2401.
[27] Midgley A, Beresford MW. Cellular localization of nuclear antigen during neutrophil apoptosis:mechanism for auto-antigen exposure?[J]. Lupus, 2011, 20(6):641-646.
[28] Midgley A, Beresford MW. PReS-FINAL-2339:Blocking interferon alpha signaling can reduce neutrophil extracellular trap formation in juvenile onset systemic lupus erythematosus[J]. Pediatr Rheumatol Online J, 2013, 11(Suppl 2):329.
[29] Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducer of type I IFN production in pediatric systmic lupus erythematosus[J]. Sci Transl Med, 2011, 3(73):73ra20.
[30] Bennett L, Palucke AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood[J]. J Exp Med, 2003, 197(6):711-723.
[31] Carmona-Rivera C, Kaplan MJ. Low-density granulocytes:a distinct class of neutrophils in systemic autoimmunity[J]. Semin Immunopathol, 2013, 35(4):455-463.
[32] Carmona-Rivera C, Zhao W, Yalavarthi S, et al. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2[J]. Ann Rheum Dis, 2015, 74(7):1417-1424.
[33] Sur Chowdhury C, Giaglis S, Walker UA, et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis:analysis of underlying signal transduction pathways and potential diagnostic utility[J]. Arthritis Res Ther, 2014, 16(3):R122.
[34] Wang Y, Xiao Y, Zhong L, et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes[J]. Diabetes, 2014, 63(12):4239-4248.
[35] Bai Y, Tong Y, Liu Y, et al. Self-dsDNA in the pathogenesis of systemic lupus erthematosus[J]. Clin Exp Immunol, 2018, 191(1):1-10.
[36] Truszewska A, Foroncewicz B, Paczek L. The role and diagnostic value of cell-free DNA in systemic lupus erthematosus[J]. Clin Exp Rheumatol, 2017, 35(2):330-336.
[37] Wang H, Li T, Chen S, et al. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin[J]. Arthritis Rheumatol, 2015, 67(12):3190-3200.
[38] Pieterse E, Hofstra J, Berden J, et al. Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus[J]. Clin Exp Immunol, 2015, 179(1):68-74.
[39] Huang W, Wu J, Yang H, et al. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage[J]. Cell Death Differ, 2017, 24(2):263-275.
[40] Handono K, Sidarta YO, Pradana BA, et al. Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus[J]. Acta Med Indones, 2014, 46(3):189-198.
[41] Giaglis S, Hahn S, Hasler P. "The NET Outcome":Are neutrophil extracellular traps of any relevance to the pathophysiology of autoimmune disorders in childhood?[J]. Front Pediatr, 2016, 4:97.
[42] Midgley A, Watson L, Beresford MW. New insights into the pathogenesis and management of lupus in children[J]. Arch Dis Child, 2014, 99(6):563-567.
[43] Rocha Arrieta YC, Rojas M, Vasquez G, et al. The lymphocytes stimulation induced DNA release, a phenomenon similar to NETosis[J]. Scand J Immunol, 2017, 86(4):229-238.
[44] Gordon RA, Herter JM, Rosetti F, et al. Lupus and proliferative nephritis are PAD4 independent in murine models[J]. JCI Insight, 2017, 2(10):92926.
[45] Jacob CO, Yu N, Yoo DG, et al. Haploinsufficiency of NADPH oxidase subunit neutrophil cytosolic factor 2 is sufficient to accelerate full-blown lupus in NZM 2328 Mice[J]. Arthritis Rheumatol, 2017, 69(8):1647-1660.